nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—kidney cancer	0.292	1	CbGaD
Zafirlukast—ABCG2—Pazopanib—kidney cancer	0.0391	0.0788	CbGbCtD
Zafirlukast—ABCG2—Dactinomycin—kidney cancer	0.0358	0.0721	CbGbCtD
Zafirlukast—ABCG2—Erlotinib—kidney cancer	0.0279	0.0562	CbGbCtD
Zafirlukast—ABCG2—Paclitaxel—kidney cancer	0.0255	0.0515	CbGbCtD
Zafirlukast—CYP2D6—Temsirolimus—kidney cancer	0.0253	0.051	CbGbCtD
Zafirlukast—CYP3A4—Everolimus—kidney cancer	0.0238	0.048	CbGbCtD
Zafirlukast—ABCG2—Sorafenib—kidney cancer	0.0227	0.0457	CbGbCtD
Zafirlukast—ABCG2—Vincristine—kidney cancer	0.022	0.0444	CbGbCtD
Zafirlukast—CYP2C8—Pazopanib—kidney cancer	0.0208	0.042	CbGbCtD
Zafirlukast—ABCG2—Sunitinib—kidney cancer	0.0184	0.037	CbGbCtD
Zafirlukast—CYP1A2—Pazopanib—kidney cancer	0.0161	0.0325	CbGbCtD
Zafirlukast—CYP3A4—Temsirolimus—kidney cancer	0.0161	0.0324	CbGbCtD
Zafirlukast—CYP2C9—Capecitabine—kidney cancer	0.0152	0.0305	CbGbCtD
Zafirlukast—CYP2C8—Erlotinib—kidney cancer	0.0149	0.03	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—kidney cancer	0.0138	0.0277	CbGbCtD
Zafirlukast—CYP2C8—Paclitaxel—kidney cancer	0.0136	0.0274	CbGbCtD
Zafirlukast—CYP2D6—Pazopanib—kidney cancer	0.0133	0.0268	CbGbCtD
Zafirlukast—CYP2C8—Sorafenib—kidney cancer	0.0121	0.0244	CbGbCtD
Zafirlukast—CYP1A2—Erlotinib—kidney cancer	0.0115	0.0232	CbGbCtD
Zafirlukast—CYP2C19—Sorafenib—kidney cancer	0.0101	0.0204	CbGbCtD
Zafirlukast—CYP2C9—Paclitaxel—kidney cancer	0.00949	0.0191	CbGbCtD
Zafirlukast—CYP2D6—Erlotinib—kidney cancer	0.00948	0.0191	CbGbCtD
Zafirlukast—CYP1A2—Sorafenib—kidney cancer	0.00935	0.0189	CbGbCtD
Zafirlukast—CYP3A4—Pazopanib—kidney cancer	0.00845	0.017	CbGbCtD
Zafirlukast—CYP2C9—Sorafenib—kidney cancer	0.00843	0.017	CbGbCtD
Zafirlukast—CYP2D6—Sorafenib—kidney cancer	0.00771	0.0155	CbGbCtD
Zafirlukast—CYP2D6—Vinblastine—kidney cancer	0.00761	0.0153	CbGbCtD
Zafirlukast—CYP3A4—Erlotinib—kidney cancer	0.00603	0.0121	CbGbCtD
Zafirlukast—CYP3A4—Paclitaxel—kidney cancer	0.00552	0.0111	CbGbCtD
Zafirlukast—CYP3A4—Sorafenib—kidney cancer	0.0049	0.00988	CbGbCtD
Zafirlukast—CYP3A4—Vinblastine—kidney cancer	0.00484	0.00975	CbGbCtD
Zafirlukast—CYP3A4—Vincristine—kidney cancer	0.00476	0.00959	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—kidney cancer	0.00468	0.00942	CbGbCtD
Zafirlukast—CYP3A4—Sunitinib—kidney cancer	0.00397	0.008	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—kidney cancer	0.00297	0.00599	CbGbCtD
Zafirlukast—CYP2C19—urine—kidney cancer	0.00173	0.14	CbGeAlD
Zafirlukast—CYP1A2—urine—kidney cancer	0.00141	0.115	CbGeAlD
Zafirlukast—CYP2C9—urine—kidney cancer	0.00134	0.109	CbGeAlD
Zafirlukast—CYP2E1—urine—kidney cancer	0.00127	0.103	CbGeAlD
Zafirlukast—CYP3A4—urine—kidney cancer	0.00102	0.0829	CbGeAlD
Zafirlukast—CYP2D6—urine—kidney cancer	0.001	0.0816	CbGeAlD
Zafirlukast—Tolvaptan—ABCB1—kidney cancer	0.000475	0.768	CrCbGaD
Zafirlukast—ABCG2—nephron tubule—kidney cancer	0.000395	0.032	CbGeAlD
Zafirlukast—CYP2C8—renal system—kidney cancer	0.000369	0.03	CbGeAlD
Zafirlukast—CYP2C8—kidney—kidney cancer	0.000357	0.029	CbGeAlD
Zafirlukast—CYP1A2—renal system—kidney cancer	0.000345	0.028	CbGeAlD
Zafirlukast—CYP2E1—nephron tubule—kidney cancer	0.000342	0.0277	CbGeAlD
Zafirlukast—CYP2E1—renal system—kidney cancer	0.000311	0.0252	CbGeAlD
Zafirlukast—CYP2E1—kidney—kidney cancer	0.0003	0.0244	CbGeAlD
Zafirlukast—PTGS1—renal system—kidney cancer	0.000299	0.0243	CbGeAlD
Zafirlukast—CYP2E1—cortex of kidney—kidney cancer	0.000292	0.0237	CbGeAlD
Zafirlukast—PTGS1—kidney—kidney cancer	0.000289	0.0235	CbGeAlD
Zafirlukast—PTGS1—cardiac atrium—kidney cancer	0.000268	0.0218	CbGeAlD
Zafirlukast—CYP3A4—renal system—kidney cancer	0.00025	0.0203	CbGeAlD
Zafirlukast—CYP2D6—renal system—kidney cancer	0.000246	0.02	CbGeAlD
Zafirlukast—CYP3A4—kidney—kidney cancer	0.000242	0.0196	CbGeAlD
Zafirlukast—CYP2D6—kidney—kidney cancer	0.000238	0.0193	CbGeAlD
Zafirlukast—Haemoglobin—Paclitaxel—kidney cancer	0.000204	0.00138	CcSEcCtD
Zafirlukast—Abdominal pain—Vinblastine—kidney cancer	0.000204	0.00138	CcSEcCtD
Zafirlukast—Headache—Pazopanib—kidney cancer	0.000204	0.00138	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000203	0.00138	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—kidney cancer	0.000203	0.00138	CcSEcCtD
Zafirlukast—Abdominal pain—Everolimus—kidney cancer	0.000203	0.00138	CcSEcCtD
Zafirlukast—Body temperature increased—Everolimus—kidney cancer	0.000203	0.00138	CcSEcCtD
Zafirlukast—Haemorrhage—Paclitaxel—kidney cancer	0.000203	0.00138	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Erlotinib—kidney cancer	0.000203	0.00137	CcSEcCtD
Zafirlukast—Hypoaesthesia—Paclitaxel—kidney cancer	0.000202	0.00137	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—kidney cancer	0.000202	0.00137	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—kidney cancer	0.000201	0.00136	CcSEcCtD
Zafirlukast—Abdominal discomfort—Capecitabine—kidney cancer	0.000199	0.00135	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dactinomycin—kidney cancer	0.000199	0.00135	CcSEcCtD
Zafirlukast—Dyspepsia—Sorafenib—kidney cancer	0.000196	0.00133	CcSEcCtD
Zafirlukast—Body temperature increased—Erlotinib—kidney cancer	0.000196	0.00133	CcSEcCtD
Zafirlukast—Abdominal pain—Erlotinib—kidney cancer	0.000196	0.00133	CcSEcCtD
Zafirlukast—Ill-defined disorder—Gemcitabine—kidney cancer	0.000196	0.00133	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000195	0.00133	CcSEcCtD
Zafirlukast—Neutropenia—Capecitabine—kidney cancer	0.000194	0.00132	CcSEcCtD
Zafirlukast—Insomnia—Sunitinib—kidney cancer	0.000194	0.00132	CcSEcCtD
Zafirlukast—Nausea—Pazopanib—kidney cancer	0.000193	0.00131	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000192	0.00131	CcSEcCtD
Zafirlukast—Fatigue—Sorafenib—kidney cancer	0.000192	0.0013	CcSEcCtD
Zafirlukast—Pain—Sorafenib—kidney cancer	0.000191	0.00129	CcSEcCtD
Zafirlukast—Malaise—Gemcitabine—kidney cancer	0.00019	0.00129	CcSEcCtD
Zafirlukast—Hypersensitivity—Vinblastine—kidney cancer	0.00019	0.00129	CcSEcCtD
Zafirlukast—Myalgia—Vincristine—kidney cancer	0.000189	0.00128	CcSEcCtD
Zafirlukast—Hypersensitivity—Everolimus—kidney cancer	0.000189	0.00128	CcSEcCtD
Zafirlukast—Dyspepsia—Sunitinib—kidney cancer	0.000189	0.00128	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000185	0.00126	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000185	0.00126	CcSEcCtD
Zafirlukast—Asthenia—Vinblastine—kidney cancer	0.000185	0.00125	CcSEcCtD
Zafirlukast—Fatigue—Sunitinib—kidney cancer	0.000185	0.00125	CcSEcCtD
Zafirlukast—Asthenia—Everolimus—kidney cancer	0.000184	0.00125	CcSEcCtD
Zafirlukast—Pain—Sunitinib—kidney cancer	0.000183	0.00124	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Sorafenib—kidney cancer	0.000182	0.00124	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Capecitabine—kidney cancer	0.000182	0.00123	CcSEcCtD
Zafirlukast—Pruritus—Everolimus—kidney cancer	0.000182	0.00123	CcSEcCtD
Zafirlukast—Oedema—Vincristine—kidney cancer	0.000181	0.00123	CcSEcCtD
Zafirlukast—Jaundice—Capecitabine—kidney cancer	0.000181	0.00123	CcSEcCtD
Zafirlukast—Infection—Vincristine—kidney cancer	0.00018	0.00122	CcSEcCtD
Zafirlukast—Arthralgia—Gemcitabine—kidney cancer	0.00018	0.00122	CcSEcCtD
Zafirlukast—Myalgia—Gemcitabine—kidney cancer	0.00018	0.00122	CcSEcCtD
Zafirlukast—Asthenia—Erlotinib—kidney cancer	0.000178	0.00121	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vincristine—kidney cancer	0.000178	0.00121	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000177	0.0012	CcSEcCtD
Zafirlukast—Discomfort—Gemcitabine—kidney cancer	0.000177	0.0012	CcSEcCtD
Zafirlukast—Urticaria—Sorafenib—kidney cancer	0.000177	0.0012	CcSEcCtD
Zafirlukast—Diarrhoea—Vinblastine—kidney cancer	0.000176	0.0012	CcSEcCtD
Zafirlukast—Abdominal pain—Sorafenib—kidney cancer	0.000176	0.0012	CcSEcCtD
Zafirlukast—Body temperature increased—Sorafenib—kidney cancer	0.000176	0.0012	CcSEcCtD
Zafirlukast—Diarrhoea—Everolimus—kidney cancer	0.000176	0.00119	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Sunitinib—kidney cancer	0.000175	0.00119	CcSEcCtD
Zafirlukast—Pruritus—Erlotinib—kidney cancer	0.000175	0.00119	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—kidney cancer	0.000175	0.00119	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—kidney cancer	0.000174	0.00118	CcSEcCtD
Zafirlukast—Agranulocytosis—Capecitabine—kidney cancer	0.000173	0.00117	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—kidney cancer	0.000173	0.00117	CcSEcCtD
Zafirlukast—Oedema—Gemcitabine—kidney cancer	0.000172	0.00117	CcSEcCtD
Zafirlukast—Infection—Gemcitabine—kidney cancer	0.000171	0.00116	CcSEcCtD
Zafirlukast—Back pain—Paclitaxel—kidney cancer	0.000171	0.00116	CcSEcCtD
Zafirlukast—Dizziness—Vinblastine—kidney cancer	0.00017	0.00116	CcSEcCtD
Zafirlukast—Dizziness—Everolimus—kidney cancer	0.00017	0.00115	CcSEcCtD
Zafirlukast—Abdominal pain—Sunitinib—kidney cancer	0.00017	0.00115	CcSEcCtD
Zafirlukast—Body temperature increased—Sunitinib—kidney cancer	0.00017	0.00115	CcSEcCtD
Zafirlukast—Diarrhoea—Erlotinib—kidney cancer	0.00017	0.00115	CcSEcCtD
Zafirlukast—Thrombocytopenia—Gemcitabine—kidney cancer	0.000168	0.00114	CcSEcCtD
Zafirlukast—Feeling abnormal—Dactinomycin—kidney cancer	0.000167	0.00114	CcSEcCtD
Zafirlukast—Haemoglobin—Capecitabine—kidney cancer	0.000167	0.00114	CcSEcCtD
Zafirlukast—Haemorrhage—Capecitabine—kidney cancer	0.000166	0.00113	CcSEcCtD
Zafirlukast—Hepatitis—Capecitabine—kidney cancer	0.000166	0.00113	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000166	0.00113	CcSEcCtD
Zafirlukast—Hypoaesthesia—Capecitabine—kidney cancer	0.000166	0.00112	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000165	0.00112	CcSEcCtD
Zafirlukast—Hypersensitivity—Sorafenib—kidney cancer	0.000164	0.00111	CcSEcCtD
Zafirlukast—Insomnia—Vincristine—kidney cancer	0.000164	0.00111	CcSEcCtD
Zafirlukast—Vomiting—Vinblastine—kidney cancer	0.000164	0.00111	CcSEcCtD
Zafirlukast—Dizziness—Erlotinib—kidney cancer	0.000164	0.00111	CcSEcCtD
Zafirlukast—Ill-defined disorder—Paclitaxel—kidney cancer	0.000164	0.00111	CcSEcCtD
Zafirlukast—Vomiting—Everolimus—kidney cancer	0.000163	0.00111	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—kidney cancer	0.000162	0.0011	CcSEcCtD
Zafirlukast—Rash—Everolimus—kidney cancer	0.000162	0.0011	CcSEcCtD
Zafirlukast—Dermatitis—Everolimus—kidney cancer	0.000162	0.0011	CcSEcCtD
Zafirlukast—Headache—Vinblastine—kidney cancer	0.000161	0.0011	CcSEcCtD
Zafirlukast—Angioedema—Paclitaxel—kidney cancer	0.000161	0.00109	CcSEcCtD
Zafirlukast—Headache—Everolimus—kidney cancer	0.000161	0.00109	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—kidney cancer	0.00016	0.00109	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—kidney cancer	0.00016	0.00109	CcSEcCtD
Zafirlukast—Asthenia—Sorafenib—kidney cancer	0.00016	0.00109	CcSEcCtD
Zafirlukast—Malaise—Paclitaxel—kidney cancer	0.000159	0.00108	CcSEcCtD
Zafirlukast—Hypersensitivity—Sunitinib—kidney cancer	0.000158	0.00107	CcSEcCtD
Zafirlukast—Pruritus—Sorafenib—kidney cancer	0.000158	0.00107	CcSEcCtD
Zafirlukast—Vomiting—Erlotinib—kidney cancer	0.000158	0.00107	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000157	0.00106	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Vincristine—kidney cancer	0.000157	0.00106	CcSEcCtD
Zafirlukast—Fatigue—Vincristine—kidney cancer	0.000156	0.00106	CcSEcCtD
Zafirlukast—Rash—Erlotinib—kidney cancer	0.000156	0.00106	CcSEcCtD
Zafirlukast—Dermatitis—Erlotinib—kidney cancer	0.000156	0.00106	CcSEcCtD
Zafirlukast—Insomnia—Gemcitabine—kidney cancer	0.000156	0.00106	CcSEcCtD
Zafirlukast—Headache—Erlotinib—kidney cancer	0.000155	0.00105	CcSEcCtD
Zafirlukast—Pain—Vincristine—kidney cancer	0.000155	0.00105	CcSEcCtD
Zafirlukast—Asthenia—Sunitinib—kidney cancer	0.000154	0.00104	CcSEcCtD
Zafirlukast—Nausea—Vinblastine—kidney cancer	0.000153	0.00104	CcSEcCtD
Zafirlukast—Nausea—Everolimus—kidney cancer	0.000153	0.00103	CcSEcCtD
Zafirlukast—Diarrhoea—Sorafenib—kidney cancer	0.000152	0.00103	CcSEcCtD
Zafirlukast—Pruritus—Sunitinib—kidney cancer	0.000152	0.00103	CcSEcCtD
Zafirlukast—Myalgia—Paclitaxel—kidney cancer	0.00015	0.00102	CcSEcCtD
Zafirlukast—Arthralgia—Paclitaxel—kidney cancer	0.00015	0.00102	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—kidney cancer	0.00015	0.00102	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000149	0.00101	CcSEcCtD
Zafirlukast—Discomfort—Paclitaxel—kidney cancer	0.000148	0.00101	CcSEcCtD
Zafirlukast—Fatigue—Gemcitabine—kidney cancer	0.000148	0.00101	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vincristine—kidney cancer	0.000148	0.00101	CcSEcCtD
Zafirlukast—Dizziness—Sorafenib—kidney cancer	0.000147	0.001	CcSEcCtD
Zafirlukast—Pain—Gemcitabine—kidney cancer	0.000147	0.000999	CcSEcCtD
Zafirlukast—Nausea—Erlotinib—kidney cancer	0.000147	0.000999	CcSEcCtD
Zafirlukast—Diarrhoea—Sunitinib—kidney cancer	0.000147	0.000996	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—kidney cancer	0.000146	0.000988	CcSEcCtD
Zafirlukast—Oedema—Paclitaxel—kidney cancer	0.000144	0.000978	CcSEcCtD
Zafirlukast—Abdominal pain—Vincristine—kidney cancer	0.000143	0.000973	CcSEcCtD
Zafirlukast—Body temperature increased—Vincristine—kidney cancer	0.000143	0.000973	CcSEcCtD
Zafirlukast—Glyburide—ABCB1—kidney cancer	0.000143	0.232	CrCbGaD
Zafirlukast—Liver function test abnormal—Doxorubicin—kidney cancer	0.000143	0.000971	CcSEcCtD
Zafirlukast—Infection—Paclitaxel—kidney cancer	0.000143	0.000971	CcSEcCtD
Zafirlukast—Dizziness—Sunitinib—kidney cancer	0.000142	0.000962	CcSEcCtD
Zafirlukast—Feeling abnormal—Gemcitabine—kidney cancer	0.000142	0.000962	CcSEcCtD
Zafirlukast—Vomiting—Sorafenib—kidney cancer	0.000142	0.000962	CcSEcCtD
Zafirlukast—Thrombocytopenia—Paclitaxel—kidney cancer	0.000141	0.000957	CcSEcCtD
Zafirlukast—Rash—Sorafenib—kidney cancer	0.000141	0.000954	CcSEcCtD
Zafirlukast—Dermatitis—Sorafenib—kidney cancer	0.00014	0.000953	CcSEcCtD
Zafirlukast—Back pain—Capecitabine—kidney cancer	0.00014	0.000951	CcSEcCtD
Zafirlukast—Headache—Sorafenib—kidney cancer	0.00014	0.000947	CcSEcCtD
Zafirlukast—Diarrhoea—Dactinomycin—kidney cancer	0.000139	0.000943	CcSEcCtD
Zafirlukast—Vomiting—Sunitinib—kidney cancer	0.000136	0.000925	CcSEcCtD
Zafirlukast—Body temperature increased—Gemcitabine—kidney cancer	0.000136	0.000923	CcSEcCtD
Zafirlukast—Rash—Sunitinib—kidney cancer	0.000135	0.000918	CcSEcCtD
Zafirlukast—Dermatitis—Sunitinib—kidney cancer	0.000135	0.000917	CcSEcCtD
Zafirlukast—Ill-defined disorder—Capecitabine—kidney cancer	0.000134	0.000912	CcSEcCtD
Zafirlukast—Headache—Sunitinib—kidney cancer	0.000134	0.000912	CcSEcCtD
Zafirlukast—Hypersensitivity—Vincristine—kidney cancer	0.000134	0.000907	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—kidney cancer	0.000133	0.0009	CcSEcCtD
Zafirlukast—Nausea—Sorafenib—kidney cancer	0.000132	0.000898	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000131	0.000891	CcSEcCtD
Zafirlukast—Malaise—Capecitabine—kidney cancer	0.000131	0.000887	CcSEcCtD
Zafirlukast—Insomnia—Paclitaxel—kidney cancer	0.00013	0.000884	CcSEcCtD
Zafirlukast—Asthenia—Vincristine—kidney cancer	0.00013	0.000883	CcSEcCtD
Zafirlukast—Vomiting—Dactinomycin—kidney cancer	0.000129	0.000876	CcSEcCtD
Zafirlukast—Rash—Dactinomycin—kidney cancer	0.000128	0.000869	CcSEcCtD
Zafirlukast—Nausea—Sunitinib—kidney cancer	0.000127	0.000864	CcSEcCtD
Zafirlukast—Dyspepsia—Paclitaxel—kidney cancer	0.000127	0.000861	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—kidney cancer	0.000125	0.00085	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000124	0.000844	CcSEcCtD
Zafirlukast—Fatigue—Paclitaxel—kidney cancer	0.000124	0.000843	CcSEcCtD
Zafirlukast—Diarrhoea—Vincristine—kidney cancer	0.000124	0.000842	CcSEcCtD
Zafirlukast—Asthenia—Gemcitabine—kidney cancer	0.000123	0.000838	CcSEcCtD
Zafirlukast—Arthralgia—Capecitabine—kidney cancer	0.000123	0.000837	CcSEcCtD
Zafirlukast—Myalgia—Capecitabine—kidney cancer	0.000123	0.000837	CcSEcCtD
Zafirlukast—Pain—Paclitaxel—kidney cancer	0.000123	0.000836	CcSEcCtD
Zafirlukast—Discomfort—Capecitabine—kidney cancer	0.000122	0.000827	CcSEcCtD
Zafirlukast—Pruritus—Gemcitabine—kidney cancer	0.000122	0.000826	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—kidney cancer	0.000121	0.000818	CcSEcCtD
Zafirlukast—Dizziness—Vincristine—kidney cancer	0.00012	0.000814	CcSEcCtD
Zafirlukast—Feeling abnormal—Paclitaxel—kidney cancer	0.000119	0.000806	CcSEcCtD
Zafirlukast—Oedema—Capecitabine—kidney cancer	0.000118	0.000802	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000118	0.000799	CcSEcCtD
Zafirlukast—Diarrhoea—Gemcitabine—kidney cancer	0.000118	0.000799	CcSEcCtD
Zafirlukast—Infection—Capecitabine—kidney cancer	0.000117	0.000797	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000117	0.000795	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—kidney cancer	0.000116	0.00079	CcSEcCtD
Zafirlukast—Thrombocytopenia—Capecitabine—kidney cancer	0.000116	0.000786	CcSEcCtD
Zafirlukast—Vomiting—Vincristine—kidney cancer	0.000115	0.000783	CcSEcCtD
Zafirlukast—Urticaria—Paclitaxel—kidney cancer	0.000114	0.000777	CcSEcCtD
Zafirlukast—Rash—Vincristine—kidney cancer	0.000114	0.000776	CcSEcCtD
Zafirlukast—Dermatitis—Vincristine—kidney cancer	0.000114	0.000775	CcSEcCtD
Zafirlukast—Abdominal pain—Paclitaxel—kidney cancer	0.000114	0.000773	CcSEcCtD
Zafirlukast—Body temperature increased—Paclitaxel—kidney cancer	0.000114	0.000773	CcSEcCtD
Zafirlukast—Headache—Vincristine—kidney cancer	0.000114	0.000771	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—kidney cancer	0.000112	0.000761	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—kidney cancer	0.000112	0.000757	CcSEcCtD
Zafirlukast—Vomiting—Gemcitabine—kidney cancer	0.000109	0.000742	CcSEcCtD
Zafirlukast—Rash—Gemcitabine—kidney cancer	0.000108	0.000736	CcSEcCtD
Zafirlukast—Dermatitis—Gemcitabine—kidney cancer	0.000108	0.000736	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—kidney cancer	0.000108	0.000732	CcSEcCtD
Zafirlukast—Headache—Gemcitabine—kidney cancer	0.000108	0.000732	CcSEcCtD
Zafirlukast—Nausea—Vincristine—kidney cancer	0.000108	0.000731	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000108	0.000731	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—kidney cancer	0.000107	0.000728	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—kidney cancer	0.000107	0.000728	CcSEcCtD
Zafirlukast—Insomnia—Capecitabine—kidney cancer	0.000107	0.000726	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—kidney cancer	0.000107	0.000724	CcSEcCtD
Zafirlukast—Hypersensitivity—Paclitaxel—kidney cancer	0.000106	0.00072	CcSEcCtD
Zafirlukast—Dyspepsia—Capecitabine—kidney cancer	0.000104	0.000706	CcSEcCtD
Zafirlukast—Asthenia—Paclitaxel—kidney cancer	0.000103	0.000701	CcSEcCtD
Zafirlukast—Nausea—Gemcitabine—kidney cancer	0.000102	0.000694	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000102	0.000693	CcSEcCtD
Zafirlukast—Fatigue—Capecitabine—kidney cancer	0.000102	0.000692	CcSEcCtD
Zafirlukast—Pruritus—Paclitaxel—kidney cancer	0.000102	0.000692	CcSEcCtD
Zafirlukast—Pain—Capecitabine—kidney cancer	0.000101	0.000686	CcSEcCtD
Zafirlukast—Diarrhoea—Paclitaxel—kidney cancer	9.86e-05	0.000669	CcSEcCtD
Zafirlukast—Feeling abnormal—Capecitabine—kidney cancer	9.74e-05	0.000661	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Capecitabine—kidney cancer	9.67e-05	0.000656	CcSEcCtD
Zafirlukast—Dizziness—Paclitaxel—kidney cancer	9.53e-05	0.000646	CcSEcCtD
Zafirlukast—Urticaria—Capecitabine—kidney cancer	9.39e-05	0.000637	CcSEcCtD
Zafirlukast—Abdominal pain—Capecitabine—kidney cancer	9.35e-05	0.000634	CcSEcCtD
Zafirlukast—Body temperature increased—Capecitabine—kidney cancer	9.35e-05	0.000634	CcSEcCtD
Zafirlukast—Vomiting—Paclitaxel—kidney cancer	9.16e-05	0.000622	CcSEcCtD
Zafirlukast—Rash—Paclitaxel—kidney cancer	9.08e-05	0.000616	CcSEcCtD
Zafirlukast—Dermatitis—Paclitaxel—kidney cancer	9.08e-05	0.000616	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—kidney cancer	9.03e-05	0.000613	CcSEcCtD
Zafirlukast—Headache—Paclitaxel—kidney cancer	9.03e-05	0.000612	CcSEcCtD
Zafirlukast—Hypersensitivity—Capecitabine—kidney cancer	8.71e-05	0.000591	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—kidney cancer	8.66e-05	0.000588	CcSEcCtD
Zafirlukast—Nausea—Paclitaxel—kidney cancer	8.56e-05	0.000581	CcSEcCtD
Zafirlukast—Asthenia—Capecitabine—kidney cancer	8.48e-05	0.000576	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—kidney cancer	8.42e-05	0.000571	CcSEcCtD
Zafirlukast—Pruritus—Capecitabine—kidney cancer	8.36e-05	0.000568	CcSEcCtD
Zafirlukast—Diarrhoea—Capecitabine—kidney cancer	8.09e-05	0.000549	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—kidney cancer	7.95e-05	0.000539	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—kidney cancer	7.95e-05	0.000539	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—kidney cancer	7.85e-05	0.000533	CcSEcCtD
Zafirlukast—Dizziness—Capecitabine—kidney cancer	7.82e-05	0.000531	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—kidney cancer	7.62e-05	0.000517	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—kidney cancer	7.57e-05	0.000514	CcSEcCtD
Zafirlukast—Vomiting—Capecitabine—kidney cancer	7.52e-05	0.00051	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—kidney cancer	7.46e-05	0.000506	CcSEcCtD
Zafirlukast—Rash—Capecitabine—kidney cancer	7.45e-05	0.000506	CcSEcCtD
Zafirlukast—Dermatitis—Capecitabine—kidney cancer	7.45e-05	0.000505	CcSEcCtD
Zafirlukast—Headache—Capecitabine—kidney cancer	7.41e-05	0.000503	CcSEcCtD
Zafirlukast—Nausea—Capecitabine—kidney cancer	7.02e-05	0.000477	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.94e-05	0.000471	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—kidney cancer	6.89e-05	0.000468	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—kidney cancer	6.71e-05	0.000455	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.58e-05	0.000446	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—kidney cancer	6.57e-05	0.000446	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—kidney cancer	6.52e-05	0.000442	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—kidney cancer	6.28e-05	0.000426	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—kidney cancer	6.23e-05	0.000423	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—kidney cancer	6.05e-05	0.000411	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—kidney cancer	6.02e-05	0.000409	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—kidney cancer	6.02e-05	0.000409	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—kidney cancer	5.62e-05	0.000381	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—kidney cancer	5.47e-05	0.000371	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—kidney cancer	5.39e-05	0.000366	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—kidney cancer	5.21e-05	0.000354	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—kidney cancer	5.04e-05	0.000342	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—kidney cancer	4.85e-05	0.000329	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—kidney cancer	4.81e-05	0.000326	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—kidney cancer	4.8e-05	0.000326	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—kidney cancer	4.77e-05	0.000324	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—kidney cancer	4.53e-05	0.000307	CcSEcCtD
Zafirlukast—CYP1A2—Metabolism—PPAT—kidney cancer	1.32e-05	0.000256	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CA2—kidney cancer	1.31e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK3—kidney cancer	1.31e-05	0.000255	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PSMD7—kidney cancer	1.3e-05	0.000254	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.3e-05	0.000253	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SCARB1—kidney cancer	1.29e-05	0.000251	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALAD—kidney cancer	1.29e-05	0.000251	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.29e-05	0.000251	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PGK1—kidney cancer	1.28e-05	0.000249	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.28e-05	0.000249	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALAD—kidney cancer	1.28e-05	0.000249	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—kidney cancer	1.27e-05	0.000248	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CA—kidney cancer	1.27e-05	0.000247	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RAF1—kidney cancer	1.26e-05	0.000245	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.26e-05	0.000245	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LDHB—kidney cancer	1.26e-05	0.000245	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RELA—kidney cancer	1.25e-05	0.000244	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PSMD7—kidney cancer	1.25e-05	0.000244	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PDHB—kidney cancer	1.25e-05	0.000243	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.25e-05	0.000243	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK1—kidney cancer	1.24e-05	0.000242	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ERBB2—kidney cancer	1.24e-05	0.000242	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—POMC—kidney cancer	1.24e-05	0.000242	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—BCHE—kidney cancer	1.23e-05	0.00024	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.23e-05	0.000239	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MTOR—kidney cancer	1.23e-05	0.000239	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—FH—kidney cancer	1.22e-05	0.000238	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APRT—kidney cancer	1.22e-05	0.000238	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CA9—kidney cancer	1.22e-05	0.000238	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC5A5—kidney cancer	1.22e-05	0.000238	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.22e-05	0.000237	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CRABP1—kidney cancer	1.2e-05	0.000234	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.2e-05	0.000233	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.19e-05	0.000232	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—BCHE—kidney cancer	1.19e-05	0.000231	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PGK1—kidney cancer	1.18e-05	0.000229	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.18e-05	0.000229	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC2A1—kidney cancer	1.18e-05	0.000229	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KRAS—kidney cancer	1.18e-05	0.000229	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CCBL1—kidney cancer	1.17e-05	0.000228	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC5A5—kidney cancer	1.17e-05	0.000228	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PGK1—kidney cancer	1.17e-05	0.000227	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.17e-05	0.000227	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LDHB—kidney cancer	1.16e-05	0.000225	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN1B—kidney cancer	1.15e-05	0.000224	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPC3—kidney cancer	1.15e-05	0.000224	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LDHB—kidney cancer	1.15e-05	0.000223	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC2A1—kidney cancer	1.13e-05	0.00022	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—kidney cancer	1.13e-05	0.00022	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.12e-05	0.000219	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CA2—kidney cancer	1.12e-05	0.000218	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ITPR2—kidney cancer	1.12e-05	0.000217	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—kidney cancer	1.1e-05	0.000214	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.1e-05	0.000214	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—JUN—kidney cancer	1.1e-05	0.000214	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALAD—kidney cancer	1.09e-05	0.000213	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CA9—kidney cancer	1.09e-05	0.000212	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CTNNB1—kidney cancer	1.09e-05	0.000212	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—kidney cancer	1.08e-05	0.00021	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.07e-05	0.000207	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.06e-05	0.000207	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—kidney cancer	1.06e-05	0.000207	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—kidney cancer	1.04e-05	0.000203	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.04e-05	0.000203	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CRABP1—kidney cancer	1.04e-05	0.000202	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTT1—kidney cancer	1.02e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ACHE—kidney cancer	1.02e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.02e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPAT—kidney cancer	1.02e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CA9—kidney cancer	1e-05	0.000195	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PGK1—kidney cancer	9.98e-06	0.000194	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC5A3—kidney cancer	9.98e-06	0.000194	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CA9—kidney cancer	9.93e-06	0.000193	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GSTP1—kidney cancer	9.82e-06	0.000191	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LDHB—kidney cancer	9.79e-06	0.000191	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.71e-06	0.000189	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ITPR2—kidney cancer	9.64e-06	0.000188	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SCARB1—kidney cancer	9.63e-06	0.000188	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—kidney cancer	9.58e-06	0.000187	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.57e-06	0.000186	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS1—kidney cancer	9.53e-06	0.000186	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APRT—kidney cancer	9.45e-06	0.000184	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FH—kidney cancer	9.45e-06	0.000184	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GSTP1—kidney cancer	9.44e-06	0.000184	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PSMD7—kidney cancer	9.35e-06	0.000182	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—kidney cancer	9.3e-06	0.000181	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CRABP1—kidney cancer	9.26e-06	0.00018	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK3—kidney cancer	9.07e-06	0.000177	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GSTM1—kidney cancer	9.03e-06	0.000176	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—kidney cancer	8.93e-06	0.000174	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.89e-06	0.000173	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPC3—kidney cancer	8.88e-06	0.000173	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—BCHE—kidney cancer	8.86e-06	0.000173	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—kidney cancer	8.82e-06	0.000172	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTT1—kidney cancer	8.8e-06	0.000171	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ACHE—kidney cancer	8.8e-06	0.000171	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC5A5—kidney cancer	8.76e-06	0.000171	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GSTM1—kidney cancer	8.67e-06	0.000169	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA2—kidney cancer	8.64e-06	0.000168	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK1—kidney cancer	8.63e-06	0.000168	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ITPR2—kidney cancer	8.61e-06	0.000168	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP1A1—kidney cancer	8.56e-06	0.000167	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CRABP1—kidney cancer	8.52e-06	0.000166	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CA9—kidney cancer	8.49e-06	0.000165	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC2A1—kidney cancer	8.46e-06	0.000165	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CRABP1—kidney cancer	8.44e-06	0.000164	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALAD—kidney cancer	8.42e-06	0.000164	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SCARB1—kidney cancer	8.33e-06	0.000162	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.29e-06	0.000162	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS1—kidney cancer	8.24e-06	0.000161	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP1A1—kidney cancer	8.22e-06	0.00016	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.22e-06	0.00016	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KRAS—kidney cancer	8.15e-06	0.000159	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PSMD7—kidney cancer	8.08e-06	0.000157	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.03e-06	0.000156	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.94e-06	0.000155	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ITPR2—kidney cancer	7.92e-06	0.000154	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTT1—kidney cancer	7.85e-06	0.000153	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ACHE—kidney cancer	7.85e-06	0.000153	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ITPR2—kidney cancer	7.85e-06	0.000153	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PGK1—kidney cancer	7.7e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.7e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—BCHE—kidney cancer	7.66e-06	0.000149	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.57e-06	0.000147	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LDHB—kidney cancer	7.55e-06	0.000147	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—kidney cancer	7.48e-06	0.000146	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SCARB1—kidney cancer	7.43e-06	0.000145	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS1—kidney cancer	7.36e-06	0.000143	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.31e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—kidney cancer	7.24e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.24e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ACHE—kidney cancer	7.22e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTT1—kidney cancer	7.22e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CRABP1—kidney cancer	7.22e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PSMD7—kidney cancer	7.21e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTT1—kidney cancer	7.16e-06	0.000139	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ACHE—kidney cancer	7.16e-06	0.000139	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.09e-06	0.000138	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTP1—kidney cancer	7.05e-06	0.000137	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—BCHE—kidney cancer	6.84e-06	0.000133	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SCARB1—kidney cancer	6.83e-06	0.000133	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SCARB1—kidney cancer	6.78e-06	0.000132	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS1—kidney cancer	6.77e-06	0.000132	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.76e-06	0.000132	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.75e-06	0.000132	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ITPR2—kidney cancer	6.71e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS1—kidney cancer	6.71e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—kidney cancer	6.68e-06	0.00013	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PSMD7—kidney cancer	6.64e-06	0.000129	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PSMD7—kidney cancer	6.58e-06	0.000128	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA9—kidney cancer	6.55e-06	0.000128	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.52e-06	0.000127	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTM1—kidney cancer	6.48e-06	0.000126	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—POMC—kidney cancer	6.38e-06	0.000124	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.33e-06	0.000123	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—BCHE—kidney cancer	6.29e-06	0.000123	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—BCHE—kidney cancer	6.24e-06	0.000121	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.21e-06	0.000121	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.18e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.18e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.16e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1A1—kidney cancer	6.14e-06	0.00012	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—POMC—kidney cancer	6.13e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ACHE—kidney cancer	6.12e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTT1—kidney cancer	6.12e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTP1—kidney cancer	6.1e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A1—kidney cancer	6e-06	0.000117	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.95e-06	0.000116	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SCARB1—kidney cancer	5.79e-06	0.000113	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.77e-06	0.000112	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—kidney cancer	5.77e-06	0.000112	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS1—kidney cancer	5.73e-06	0.000112	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PSMD7—kidney cancer	5.62e-06	0.000109	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—kidney cancer	5.6e-06	0.000109	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CRABP1—kidney cancer	5.57e-06	0.000108	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.52e-06	0.000108	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTP1—kidney cancer	5.44e-06	0.000106	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BCHE—kidney cancer	5.33e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.31e-06	0.000103	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.26e-06	0.000103	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ITPR2—kidney cancer	5.18e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—kidney cancer	5.15e-06	0.0001	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—kidney cancer	5.09e-06	9.91e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.08e-06	9.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.03e-06	9.8e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTP1—kidney cancer	5e-06	9.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—kidney cancer	5e-06	9.74e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTP1—kidney cancer	4.96e-06	9.66e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.93e-06	9.61e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—kidney cancer	4.89e-06	9.52e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.74e-06	9.23e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—kidney cancer	4.74e-06	9.23e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ACHE—kidney cancer	4.72e-06	9.19e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTT1—kidney cancer	4.72e-06	9.19e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—kidney cancer	4.7e-06	9.15e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—kidney cancer	4.6e-06	8.96e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—POMC—kidney cancer	4.58e-06	8.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—kidney cancer	4.56e-06	8.88e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SCARB1—kidney cancer	4.47e-06	8.7e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—kidney cancer	4.44e-06	8.64e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS1—kidney cancer	4.42e-06	8.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.36e-06	8.5e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.36e-06	8.49e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PSMD7—kidney cancer	4.34e-06	8.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.32e-06	8.42e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.3e-06	8.38e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—kidney cancer	4.26e-06	8.31e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTP1—kidney cancer	4.24e-06	8.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BCHE—kidney cancer	4.11e-06	8.01e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.06e-06	7.91e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—kidney cancer	4.01e-06	7.82e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—POMC—kidney cancer	3.96e-06	7.71e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.92e-06	7.64e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—kidney cancer	3.9e-06	7.59e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.89e-06	7.59e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.69e-06	7.19e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—kidney cancer	3.65e-06	7.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.55e-06	6.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—POMC—kidney cancer	3.53e-06	6.88e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTP1—kidney cancer	3.27e-06	6.37e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—POMC—kidney cancer	3.25e-06	6.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—POMC—kidney cancer	3.22e-06	6.28e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—kidney cancer	3.19e-06	6.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—kidney cancer	3.16e-06	6.15e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—kidney cancer	3.13e-06	6.1e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—kidney cancer	3.1e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.03e-06	5.91e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—kidney cancer	3.01e-06	5.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—kidney cancer	3.01e-06	5.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.85e-06	5.55e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—kidney cancer	2.82e-06	5.49e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—kidney cancer	2.75e-06	5.36e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—POMC—kidney cancer	2.75e-06	5.36e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—kidney cancer	2.59e-06	5.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—kidney cancer	2.57e-06	5.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—kidney cancer	2.46e-06	4.79e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—kidney cancer	2.26e-06	4.4e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—kidney cancer	2.25e-06	4.38e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—kidney cancer	2.24e-06	4.37e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—kidney cancer	2.2e-06	4.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—POMC—kidney cancer	2.13e-06	4.14e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.94e-06	3.78e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—kidney cancer	1.92e-06	3.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.73e-06	3.38e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—kidney cancer	1.7e-06	3.3e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.6e-06	3.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.58e-06	3.08e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—kidney cancer	1.48e-06	2.88e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.35e-06	2.63e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.04e-06	2.03e-05	CbGpPWpGaD
